Practical Biostatistics

Size, follow-up, data analysis—good; post hoc analysis, interpretation—not so much


 

It’s easy to know whether a critique of some article or other was written by a statistician or a methodologist—it states how badly the study was done and how incompetently the data were analyzed. Indeed, it is extremely easy to criticize any study, no matter how well it was conducted, because all applied research involves compromises of one sort or another. Well, be prepared for a surprise. In this column, we will be discussing a study that we believe was carried out well and analyzed correctly. That’s not to say that we agree with their conclusions (we don’t), but at least the study yields data that people can argue about without dismissing the paper as a whole.

Click on the PDF icon at the top of this introduction to read the full article.

Recommended Reading

Medicare to Cover Provenge Vaccine for Prostate Cancer
MDedge Hematology and Oncology
Drug Shortages Spreading, Leading to Higher Costs
MDedge Hematology and Oncology
House Lawmakers Debate the IPAB
MDedge Hematology and Oncology
Editorial: E-Prescribing Update
MDedge Hematology and Oncology
Feds to Fund Nonprofit Insurance Plans
MDedge Hematology and Oncology
Feds Preview Medicare Pay Bundling Regulations
MDedge Hematology and Oncology
Debt Debate Rages On: The Policy & Practice Podcast
MDedge Hematology and Oncology
Hospitals See Spike in Palliative Care Teams
MDedge Hematology and Oncology
Feds: Health Spending Growth Low in 2010
MDedge Hematology and Oncology
IOM: Replace the 510(k) Device Process
MDedge Hematology and Oncology